Analysis

Science No Salve For J&J In Talc Cases, $417M Verdict Shows

Law360, Los Angeles (August 22, 2017, 11:45 PM EDT) -- Johnson & Johnson's $417 million loss in the first California jury trial over the alleged link between its talcum products and ovarian cancer, following a string of defeats in Missouri, highlights the drugmaker's uphill battle in using science to try and convince emotional jurors it hasn't lied to consumers.

A Los Angeles jury on Monday awarded $417 million to plaintiff Eva Echeverria, finding her daily application of J&J’s Johnson’s Baby Powder to her genital area for decades was the cause of her terminal ovarian cancer —...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.